Please assess the completion status of the following clinical trial:

Trial Title: Statins in Children With Type 1 Diabetes and Hypercholesterolemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:Project 1~* T1DM diagnosed clinically for \> 1 year~* any HbA1C~* on stable insulin therapy~* Ages: 10 - 20 years~* both genders~* BMI \< 85th percentile~* Fasting LDL-C\>100mg/dl~* Normal thyroid function~Inclusion Criteria:Projects 2 and 3~* T1DM diagnosed clinically for \> 3 year~* HbA1C \> 8%~* on stable insulin therapy~* Ages: 12- 20 years~* both genders~* BMI \< 85th percentile~* Fasting LDL-C\>100mg/dl~* Normal thyroid function~Exclusion Criteria:Projects 1,2 and 3~* Severe dyslipidemia (LDL-C \>160, TG \> 400 mg/dl)~* Smoking~* Pregnancy~* Current use of anti-inflammatory or immunomodulatory drugs, lipid lowering, antidiabetic drugs~* Patients with hypertension and/or microalbuminuria will be allowed using balanced randomization and standardized treatment

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: 20 Years
- Healthy Volunteers: t

Study Arms:
- Atorvastatin (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).